Search research articles
Contact Us
Filters
Showing results (1-10 of 101) with videos related to
Page
of 11
Sort By:
Organic Letters
|
October 24, 2012
Synthesis of the C20-C32 tetrahydropyran core of the phorboxazoles and the C22 epimer via a stereodivergent Michael reaction
Paul A Clarke, Kristaps Ermanis
Cancer Cell
|
April 13, 2011
Resisting targeted therapy: fifty ways to leave your EGFR
Paul Workman, Paul A Clarke
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2011
Phosphatidylinositide-3-kinase inhibitors: addressing questions of isoform selectivity and pharmacodynamic/predictive biomarkers in early clinical trials
Paul A Clarke, Paul Workman
Organic Letters
|
September 9, 2005
A racemic synthesis of an AB-ring system of hexacyclinic acid
Paul A Clarke, Andrew P Cridland
Molecular Oncology
|
March 24, 2012
Discovery of small molecule cancer drugs: successes, challenges and opportunities
Swen Hoelder, Paul A Clarke, Paul Workman
Current Cancer Drug Targets
|
October 8, 2003
Genes and proteins governing the cellular sensitivity to HSP90 inhibitors: a mechanistic perspective
Alison Maloney, Paul A Clarke, Paul Workman
Organic Letters
|
December 6, 2002
Diastereoselective synthesis of highly substituted tetrahydropyran-4-ones
Paul A Clarke, William H C Martin
Organic & Biomolecular Chemistry
|
November 19, 2011
Synthesis of the complete series of mono acetates of N-acetyl-D-neuraminic acid
Paul A Clarke, Nimesh Mistry, Gavin H Thomas
Cancer Cell
|
September 6, 2008
Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis
Marissa V Powers, Paul A Clarke, Paul Workman
Organic & Biomolecular Chemistry
|
April 19, 2014
Strategies for the construction of tetrahydropyran rings in the synthesis of natural products
Nadiah Mad Nasir, Kristaps Ermanis, Paul A Clarke
Page
of 11
Search research articles
Search
Showing results (1-10 of 101) with videos related to
Sort By:
Page
of 11
Organic Letters
|
October 24, 2012
Synthesis of the C20-C32 tetrahydropyran core of the phorboxazoles and the C22 epimer via a stereodivergent Michael reaction
Paul A Clarke, Kristaps Ermanis
Cancer Cell
|
April 13, 2011
Resisting targeted therapy: fifty ways to leave your EGFR
Paul Workman, Paul A Clarke
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2011
Phosphatidylinositide-3-kinase inhibitors: addressing questions of isoform selectivity and pharmacodynamic/predictive biomarkers in early clinical trials
Paul A Clarke, Paul Workman
Organic Letters
|
September 9, 2005
A racemic synthesis of an AB-ring system of hexacyclinic acid
Paul A Clarke, Andrew P Cridland
Molecular Oncology
|
March 24, 2012
Discovery of small molecule cancer drugs: successes, challenges and opportunities
Swen Hoelder, Paul A Clarke, Paul Workman
Current Cancer Drug Targets
|
October 8, 2003
Genes and proteins governing the cellular sensitivity to HSP90 inhibitors: a mechanistic perspective
Alison Maloney, Paul A Clarke, Paul Workman
Organic Letters
|
December 6, 2002
Diastereoselective synthesis of highly substituted tetrahydropyran-4-ones
Paul A Clarke, William H C Martin
Organic & Biomolecular Chemistry
|
November 19, 2011
Synthesis of the complete series of mono acetates of N-acetyl-D-neuraminic acid
Paul A Clarke, Nimesh Mistry, Gavin H Thomas
Cancer Cell
|
September 6, 2008
Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis
Marissa V Powers, Paul A Clarke, Paul Workman
Organic & Biomolecular Chemistry
|
April 19, 2014
Strategies for the construction of tetrahydropyran rings in the synthesis of natural products
Nadiah Mad Nasir, Kristaps Ermanis, Paul A Clarke
Page
of 11